ABSTRACT
INTRODUCTION
aricose veins represents 10-20% of global population.(1) Open surgery is the gold stander in the treatment of the varicose veins.(2)Surgery improves lower limb symptoms, venous haemodynamics and health-related quality of life (HRQL), (3) (4) (5) (6) (7) but, it is associated with complications, morbidity, and delayed return to normal activities. (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) Thomasset (18) concluded that UGFS represents an alternative offer to surgical treatment for varicose vein and confirmed that it is effective and safe. The aim of our study to assess the efficacy and safety of UGFS with a saphenous trunk varicose vein in the Vascular Surgery Unit, in Faculty of Medicine, Zagazig University as an initial experience.
PATIENTS AND METHODS -In this study, 170 patients had isolated long saphenous vein (LSV) reflux associated with SFJ incompetence, they were selected for ultrasound-guided foam Sclerotherapy (UGFS) at the Vascular Surgery Unit, between September 2010 and December2011.We excluded patients with pregnancy or patients with a history of deep vein thrombosis, thrombophilia, active thrombophlebitis, allergy to pilodocanol, bronchial asthma, myocardial ischemia, patent foramen oval on echocardiography, arterial insufficiency with an ankle brachial index of less than 0.8 local infection in the area of sclerotherapy, and patients with varicosities involving veins other than (LSV). The Institutional Review Board has approved the study and a written informed consent was obtained from the entire patients before the procedure. -Prior to the procedure: All patients were examined clinically to evaluate the severity of the venous disease using VCSS looking for the presence of varicose veins, edema, inflammation, hyperpigmentation and lipodermatosclerosis (19) and examined by duplex to determine the site of reflux along the long saphenous vein. -2 weeks and 6 months after sclerotherapy: Patients were examined clinically for complications of sclerotherapy, evaluation of the severity of the disease using the VCSS, and follow up venous duplex was done Duplex evaluation -All patients included in this study were examined using Color Duplex Ultrasonography from groin to ankle in both lower limbs using Ten out of 19 cases of partial recanalization showed reflux and complete occlusion was achieved in these cases by a second treatment session that was done in the first follow up. The rest 9 cases showed partial recanalization without reflux and no treatment to them was needed. The success rate was 93.5%, 2 weeks after the first treatment session, and the failure rate was 6.5% (Table 1) .
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Ultrasound Guided Foam Sclerotherapy…….. There was significant improvement of VCSS 2 weeks following the UGFS in comparison to pre-intervention VCSS, where P value was < 0.0001 (Table 2) . Table 2 . The P value compared (2 weeks) VCSS to Pre-intervention VCSS.
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Complications detected in 23 cases (Table  3) . Thrombophlebitis detected in 8 cases (8/154) 5.1% and treated by a n a l g e s i a and compression. DVT detected in 3 cases (3/154) 1.9%, in the calf veins in 2 of them but in the common femoral vein in the third one, all three cases treated with anticoagulant(low molecular weight heparin followed by warfarine for 6 months). Pain detected in 12 cases (12/154) 7.8% and treated by analgesia.
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Six months:
Six month after first treatment session 133 cases presented in the second follow up but 21 cases dropped out ( Chart 2). The treated veins showed complete occlusion in 102 cases (102/133) 76% after first treatment session. Total recanalization of the treated veins was in 4 cases (4/133) 3% after the first treatment session and a second treatment session was done. Partial recanalization in the treated veins was detected in 27 cases, 12 of them with reflux but the rest 15 cases without reflux. Eight of 12 cases whose treated veins showed partial recanalization with reflux after 2 treatment sessions but the rest 4 cases after single first session. All these 12 cases were treated by another treatment session. Nine out of 15 their treated veins showed partial occlusion without reflux in the second f o l l o w up although; they showed total occlusion in the first follow up. The rest 6 cases their treated veins showed partial occlusion without reflux in the first and second follow up. All those 15 cases took no treatment. The success rate was 88%, 6 months after the first treatment session, and the failure rate was 12% (Table 4) .
Table 4. Success and failure rate of UGFS after 6 months
There was significant improvement of VCSS 6 months following the UGFS in comparison to pre-intervention VCSS, where P value was < 0.0001, but there was no significant improvement of the VCSS 6 months following UGFS in comparison to 2 weeks VCSS where P value was 0.056 (Table 5) . Skin staining was found in 14.3 % of cases (19/133) six month (Table 6 ) . (27) 81% of the treated GSV with foam therapy remained occluded after3 years or more. Also, Thomasset S.C. et al, (18) reported that, with 3 months as a median time of follow up 79% of cases showed complete occlusion of target veins, 14% showed partial occlusion and the rest 6% showed complete patency. The target veins in this study were the great saphenous vein, small saphenous vein, accessory great saphenous, other unnamed veins or more than a single target vein. Figueiredo, et al, (20) reported that the success rate of cases of sclerotherapy group that showed total occlusion or partial occlusion without reflux was 78% in 6 month following treatment. This study also, reported that the great saphenous vein treated vessels in sclerotherapy group showed a success rate 80%. In the study done by OHare, (28) et al the target vein occlusion was 93% by Doppler at 2 weeks follow up and 74% by Duplex at six month follow up. The treated veins in this study included the great saphenous vein (GSV), small saphenous vein (SSV), anterior accessory saphenous vein (AASV) or other recurrent veins with significant proximal incompetent deep venous connection. Also, Hamel-Desnos, et al, (29) reported that 100% of cases showed total occlusion and absence of reflux of the target veins at the 28 th day in both with and without compression groups. The target vein in this study was either GSV or SSV. In our study the success rate after 2 weeks was (93.5%) (144/154), where complete occlusion detected by Duplex in the treated venous segment was found in 135 cases (87.7%) and partial recanlization without reflux in 9 cases (5.8%). The failure rate was (6.5%) (10/154), where the treated veins showed partial recanalization with reflux. Complete occlusion of the treated venous segment of these ten cases was achieved with a second treatment session that was done in the first follow up. Six months after first treatment session, the success rate was (117/133) 88%, where the treated veins showed complete occlusion in 102 cases (102/133) 76.6% and 15 cases (15/133) 11.3% showed partial recanalization without reflux. Failure rate was (16/133) 12% where the treated veins showed complete recanalization in 4 cases (4/133) 3% and partial recanalization with reflux in 12 cases (12/133) 9%. In our study there was significant improvement of VCSS2 weeks following the UGFS in comparison to pre intervention VCSS , where P value was < 0.0001. Also, there was significant improvement of VCSS 6 months following the UGFS in comparison to pre intervention VCSS , where P value was < 0.0001, but there was no significant improvement of the VCSS 6 months following UGFS in comparison to 2 weeks VCSS where P value was 0.056 . This result is similar to that reported by Figueiredo et al, (20) who found a statistical significant improvement for pain, oedema and inflammation in both surgery and sclerotherapy groups, when VCSS was obtained before and after treatment. Guex, et al (30) reported in large multicentre studies that UGFS associated with a low rate of significant complications. Stroke, (31) anaphylaxis (24) and pulmonary embolism (32, 33) were extremely rare described complications. Morrison, et al, (34) showed that the foam reaches the right ventricle easily with no significant complications. Also, Figueiredo, et al (20) reported that foam was always found in the deep venous system with no complications due to the small amount of foam and to high flow in the deep venous system. In a study was done by Partsch, et showed a significant worsening of telangiectases. In a series of 116 patients Thomasset et al, detected superficial thrombophlebitis in (18%), skin staining in (28%), pain in (14%), DVT in (1%), skin blistering in (1%), an allergic reaction in (1%). This study also, reported that the majority of cases of superficial thrombophlebitis happened when truncal varicosities of >10 mm were treated. The DVT described in this series was below-knee and occurred following treatment of the great saphenous vein and a varix with 15 ml 3% STS. Figueiredo, et al found that respiratory complications represent 2%, local haematoma 5%, scotomas 2%, post-foam extravasation 9%, thrombus with drainage 9% and thrombus without drainage 27%. Coleridge, reported that, UGFS complications were thrombophlebitis in 5% of patients and treated by analgesia, compression and aspiration of thrombus. DVT occurred in 11 cases, in 10 0f them the thrombus was confined to calf veins and treated by compression with elastic stocking or bandage but in the rest one case, the thrombus was confined to common femoral vein and was treated by anticoagulation. After 6 month follow up, 115 out of 457 legs showed skin pigmentation and 21 legs showed a palpable lump. In our study, in the first follow up 2 weeks after the first treatment session we detect 23 cases with complications. Thrombophlebitis detected in 8 cases (8/154) 5.1% and was treated by analgesia and compression .DVT was detected in 3 cases (3/154) 1.9%, 2 of them in calf veins and one in the common femoral vein, all the three cases were treated with anticoagulant (low molecular weight heparin followed by warfarine for 6 months ). Pain was reported in 12 cases (12/154) 7.8% and was treated by analgesia. In the second follow up assessment 6 months after t h e f i r s t t r e a t m e n t session, c o m p l i c a t i o n s w e r e detected in 19 cases (19/133) 14.3% with skin staining. Due to the limitations in our study, as it focused only on LSV, and short term follow up, more researches will be done in the future to study the effect of foam therapy in different sizes veins, to study the long term results of foam therapy and to evaluate the factors affecting the outcome of foam therapy. In conclusions USGF is effective in the treatment of saphenous trunk varicose vein and safe technique where the complications are few.
